Identifying attendance patterns in a smoking cessation treatment and their relationships with quit success
Open accessAbstract
Background While important for substance use outcomes, knowledge about treatment attendance patterns, and their relation with clinical outcomes is limited. We examined the association between attendance patterns and smoking outcomes in a randomized, controlled smoking cessation intervention trial. Methods In addition to standard smoking cessation treatment, participants were randomized to 15 weeks of an exercise intervention (n = 72) or an education control condition (n = 64). Latent class growth analysis (LCGA) tested whether intervention attendance would be better modeled as qualitatively distinct attendance patterns rather than as a single mean pattern. Multivariate generalized linear mixed modeling (GLMM) was used to evaluate associations between the attendance patterns and abstinence at the end of treatment and at 6-month follow-up. Results The LCGA solution with three patterns characterized by high probability of attendance throughout (Completers, 46.3%), gradual decreasing probability of attendance (Titrators, 23.5%), and high probability of dropout within the first few weeks (Droppers, 30.1%) provided the best fit. The GLMM analysis indicated an interaction of attendance pattern by treatment condition, such that titration was associated with lower probability of quit success for those in the control condition. Probability of quit success was not significantly different between Titrators and Completers in the exercise condition. Conclusions These findings underscore the importance of examining how treatment efficacy may vary as a function of attendance patterns. Importantly, treatment discontinuation is not necessarily indicative of poorer abstinence outcome. © 2017 Elsevier B.V.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
13 of 19 cited sources checked · 8 supported · 0 flagged · accuracy not yet measured
- Interpretationcitation
Exercise may influence smoking relapse risk factors within only a few early sessions, given evidence of rapid exercise benefits on anxiety, mood, and anxiety sensitivity.
“Given evidence of rapid benefits from exercise on anxiety, mood, and anxiety sensitivity in other studies (Medina et al., 2014; Smits et al., 2008), exercise may exert its influence on risk factors for smoking relapse in only a few sessions early on in treatment.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites Medina et al., 2014 source
The Results (section 2.2) and Discussion (section 3) report an early reduction in anxiety sensitivity during the first week of exercise, particularly among men. The paper also describes improvements in anxiety and depressive symptoms following a brief exercise intervention, but does not establish that those symptoms improved within the first few sessions. The suggestion about smoking-relapse risk factors is the citing authors’ inference, not a finding attributed to this source. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites Smits et al., 2008 sourceExperimental — accuracy not yet measured
- Premisecitation
Early abstinence success within the first 24 hours after quit predicts continued abstinence.
“Since success with abstinence within the first 24 hours after quit is predictive of continued abstinence (Perkins, 2014)”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Perkins, 2014 source
Section 3.1 (page not provided) proposes complete abstinence for at least 24 hours as a likely surrogate measure and reports that quit days during the first week predict later quit status. It does not establish that success specifically within the first 24 hours predicts continued abstinence. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Findingown data
In the control condition, Completers had a higher probability of post-treatment abstinence than Titrators (β=1.006, 95% CI [0.683, 1.329], t(3047)=6.102, p<.001).
“Completers in the control condition were more likely to be abstinent than Titrators, β=1.006, 95% CI [0.683, 1.329], t(3047)=6.102, p < .001.”
Quote in the paperSubstantial claim - Findingown data
The latent class growth analysis identified a Dropper pattern, with 41 participants (31.1%) who had a high probability of dropping out within the first few weeks.
“Droppers (n=41, 31.1%) had a high probability of dropout within the first few weeks of treatment”
Quote in the paperSubstantial claim - Findingown data
The final generalized linear mixed model found a significant interaction between attendance pattern and treatment condition for abstinence (β=0.758, 95% CI [−0.293, 1.223], t(3047)=3.195, p=.001).
“The final model yielded a significant attendance pattern by treatment interaction, β=0.758, 95% CI [−0.293, 1.223], t(3047)=3.195, p=.001”
Quote in the paperSubstantial claim
- Findingown data
Among Titrators, those in the exercise condition had a higher probability of post-treatment abstinence than those in the control condition (β=0.637, 95% CI [0.238, 1.037], t(3047)=3.127, p=.002).
“Titrators in the exercise condition were more likely to be abstinent than Titrators in the control condition, β=0.637, 95% CI [0.238, 1.037], t(3047)=3.127, p=.002.”
Quote in the paperSubstantial claim - Findingown data
The latent class growth analysis identified a Titrator pattern, with 32 participants (23.5%) whose attendance probability gradually declined over the 15 weeks.
“Titrators (n=32, 23.5%) showed a gradual decline in probability of attending throughout the 15 weeks of treatment”
Quote in the paperSubstantial claim - Findingown data
The exercise condition had a larger proportion of Droppers (28 of 72, 38.9%) than the control condition (13 of 64, 20.3%).
“or Droppers (exercise: n=28, 38.9% vs. control: n=13, 20.3%)”
Quote in the paperNot a substantial claim - Findingown data
In the exercise condition, post-treatment abstinence probability did not differ significantly between Completers and Titrators (β=0.248, 95% CI [−0.086, 0.583], t(3047)=1.455, p=0.146).
“Although the probability of abstinence at post-treatment was not significantly different between Completers and Titrators in the exercise condition, β=0.248, 95% CI [−0.086, 0.583], t(3047)=1.455, p=0.146”
Quote in the paperSubstantial claim - Findingown data
The distribution of participants across attendance patterns differed significantly between the exercise and control treatments (χ2(2)=7.46, p=.02).
“The distribution of participants following each attendance pattern was significantly different between treatments, χ2(2)=7.46, p=.02.”
Quote in the paperNot a substantial claim - Findingown data
The latent class growth analysis identified a Completer pattern, with 63 participants (46.3%) who had a high probability of attending throughout the entire treatment.
“Completers (n=63, 46.3%) had high probability of attending throughout the entire treatment duration”
Quote in the paperSubstantial claim - Findingown data
The exercise condition had a smaller proportion of Completers (26 of 72, 36.1%) than the control condition (37 of 64, 57.8%).
“there was a difference in the proportion of participants within each treatment who were Completers (exercise: n=26, 36.1% vs. control: n=37, 57.8%)”
Quote in the paperNot a substantial claim - Findingown data
The proportion of Titrators did not differ significantly between the exercise condition (18 of 72, 25.0%) and the control condition (14 of 64, 21.9%).
“whereas Titrator proportions were not significantly different (exercise: n=18, 25.0% vs. control: n=14, 21.9%)”
Quote in the paperNot a substantial claim - Findingown data
During weeks when participants were actively attending, the mean number of sessions attended was 2.51.
“On weeks that participants were actively attending treatment, the average number of sessions attended was 2.51 sessions”
Quote in the paperNot a substantial claim - Findingown data
Among Completers, post-treatment abstinence did not differ significantly between the exercise and control conditions (β=0.120, 95% CI [−0.104, 0.344], t(3047)=1.054, p=.292).
“among Completers, there were no significant differences between those in the exercise vs. the control condition, β=0.120, 95% CI [−0.104, 0.344], t(3047)=1.054, p=.292”
Quote in the paperSubstantial claim - Interpretationown data
The lower abstinence among control Titrators compared with control Completers suggests that the wellness education intervention may work through ongoing social support and accountability.
“However, Titrators in the control condition showed lower rates of abstinence compared to control Completers, suggesting that the wellness education-augmented intervention may exert its effects vis-à-vis ongoing social support and accountability.”
Quote in the paperSubstantial claim - Interpretationown data
Optimal treatment dosage may vary as a function of individuals' improvement rate.
“In conclusion, our results add to the growing literature suggesting that optimal treatment dosage may vary as a function of individuals’ improvement rate.”
Quote in the paperSubstantial claim - Study design and conductreasoning
The study was not powered specifically for the present analysis, so the lack of statistical differences between attendance patterns in the exercise condition may reflect inadequate power to detect small differences.
“Furthermore, since the study was not designed to compare treatment dosage, it was not powered specifically for the present analysis; therefore, the lack of statistical differences between attendance patterns in the exercise condition may be a reflection of inadequate power to detect small differences.”
Quote in the paperNot a substantial claim - Interpretationown data
Titrators in the exercise condition did not have significantly poorer cessation outcomes than Completers, despite attending fewer sessions.
“Titrators in the exercise condition had cessation outcomes that were not significantly different than for those completing the intervention, despite attending fewer sessions.”
Quote in the paperSubstantial claim - Study design and conductown data
Because Droppers were excluded from abstinence analyses due to missing outcome data, the ability to capture the full relationship between attendance and outcome was limited.
“Additionally, since Droppers were excluded from abstinence analyses due to lack of outcome data, our ability to capture the full scope of the relationship between treatment attendance and outcome was limited.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Attendance through the post-quit phase may be necessary to optimize benefits.
“Thus, attendance through the post-quit phase may be necessary to optimize benefits.”
Quote in the paperSubstantial claim - Interpretationcitation
These results suggest that treatment discontinuation is not necessarily an indicator of nonresponse.
“These results add to an emerging body of literature suggesting that treatment discontinuation is not necessarily an indicator of nonresponse.”
Quote in the paperSubstantial claim
- May combine two claims. 13
- Classified as probably not a substantial claim. 9
May combine two claims.
InterpretationcitationBecause early abstinence success predicts continued abstinence, Titrators who remained engaged in the exercise intervention through quit week may have benefited comparably to Completers despite lower overall attendance.
“Since success with abstinence within the first 24 hours after quit is predictive of continued abstinence (Perkins, 2014), Titrators who were likely to remain engaged in the exercise intervention through quit week may have benefited comparably to Completers despite lower overall attendance.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Perkins, 2014 source
Section 3.1 (page not specified) reports that the number of quit days in the first week predicts later quit status and proposes at least 24 hours of abstinence as a likely surrogate measure of drug efficacy. It does not specifically establish that abstinence within the first 24 hours predicts continued abstinence. The exercise-intervention comparison is the citing authors’ inference, not a claim attributed to Perkins. (LLM, conf=0.82)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationThe parent trial's core outcome analysis showed that high-AS participants randomized to exercise were more likely to remain abstinent after quit day, and session attendance had an overall positive association with abstinence.
“The core outcome analysis showed that participants high in AS randomized to exercise were more likely to remain abstinent following quit day and session attendance showed an overall positive association with abstinence (Smits et al., 2016).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Smits et al., 2016 source
May combine two claims.
Interpretationown dataThe findings expand on the main outcome paper by showing that the relation between attendance patterns and treatment success may be non-linear and may depend on the type of intervention.
“The findings reported here expand on those reported in the main outcome paper (Smits et al., 2016) by showing that the relation between attendance patterns and treatment success may not be linear and, importantly, may depend on the type of intervention.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Smits et al., 2016 source
Classified as probably not a substantial claim. May combine two claims.
PremisecitationIn another treatment trial for comorbid PTSD and SUD, a person-centered analysis derived early dropout, titration, and completion patterns, and treatment titration was not associated with poorer outcomes relative to completion.
“Another treatment trial for comorbid PTSD and SUD used a person-centered approach to empirically derive distinct attendance patterns of early dropout, titration, and completion—importantly; treatment titration was not associated with poorer outcomes relative to completion (Hien et al., 2012).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Hien et al., 2012 source
May combine two claims.
PremisecitationIn some cases, greater session attendance or treatment completion has been positively associated with outcomes, but this association is not ubiquitous, suggesting individual differences in dose-response.
“In some cases, a greater number of sessions attended or treatment completion have shown positive associations with outcomes (Baker et al., 2006; Fiore, 2008; Smits et al., 2016; Whiteley et al., 2012), but this is not ubiquitous, suggesting individual differences in dose-response exist (Baldwin et al., 2009; Barkham et al., 2006; Owen et al., 2016; Reese et al., 2011).”
Quote in the paperSubstantial claim2 of 3 sources checkedMay combine two claims.
InterpretationcitationExercise may help smoking cessation by reducing anxiety during acute withdrawal, which may be most pronounced after the initial quit attempt.
“Exercise may assist smoking cessation by mitigating anxiety during acute withdrawal symptoms (Leventhal and Zvolensky, 2015), which may be most pronounced after the initial quit attempt.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Leventhal and Zvolensky, 2015 source
The Anxiety Sensitivity section (page unavailable) reports that anxiety-related withdrawal symptoms are more pronounced early in abstinence and discusses anxiety-sensitivity interventions that may aid cessation. It does not say that exercise reduces withdrawal anxiety or helps people quit through that mechanism; its mention of vigorous exercise concerns prevention of smoking initiation, not cessation. (LLM, conf=0.78)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim. May combine two claims.
PremisecitationIn a trial of prolonged exposure with naltrexone for comorbid PTSD and alcohol dependence, both fast and slow PTSD symptom improvement and fast drinking improvement were associated with early dropout.
“in a clinical trial of prolonged exposure with naltrexone for comorbid posttraumatic stress disorder (PTSD) and alcohol dependence, both fast and slow rates of PTSD symptom improvement, as well as fast rates of drinking improvement, were each associated with early dropout (Zandberg et al., 2016).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Zandberg et al., 2016 source
The Abstract Results and Discussion report higher dropout with both very fast and very slow PTSD improvement among participants with high baseline PTSD severity, and with faster drinking improvement among participants receiving prolonged exposure. The claim omits those conditions and calls the outcome “early dropout,” whereas the reported associations concern dropout during treatment, not specifically early dropout. The Methods also show that prolonged exposure and naltrexone were separate randomized factors, not a treatment everyone received together; page numbers are unavailable in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim. May combine two claims.
PremisecitationOther studies show rapid benefits of exercise on anxiety, mood, and anxiety sensitivity.
“Given evidence of rapid benefits from exercise on anxiety, mood, and anxiety sensitivity in other studies (Medina et al., 2014; Smits et al., 2008)”
Quote in the paperSubstantial claim2 of 2 sources checkedMay combine two claims.
Findingown dataDuring active attendance weeks, 63% of participants attended all three weekly sessions, 25% attended two, and 12% attended one.
“63% attended all 3 weekly sessions, 25% attended 2 out of the 3 weekly sessions, and 12% attended only one of the 3 weekly sessions.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataA three-class latent class growth analysis solution fit the weekly attendance data better than a single pattern, with the lowest information criteria, entropy of 0.96, and a significant adjusted Lo-Mendel-Rubin likelihood ratio test (p=.01).
“The 3-class LCGA provided the best fit with lowest information criteria, high entropy (0.96) suggestive of strong delineation of classes, and a significant adjusted Lo-Mendel-Rubin likelihood ratio test, p=.01.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductcitationThe abstinence analyses followed an intent-to-treat approach recommended for smoking cessation trials.
“Following Smits et al., (2016) two dichotomous measures of smoking behavior (PPA and PA) were examined in a three-phase (i.e., pre-quit, post-quit, post-treatment) generalized linear mixed model (GLMM) following the intent-to-treat approach recommended for smoking cessation trials (Hall et al., 2001).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hall et al., 2001 source
May combine two claims.
Study design and conductreasoningThe original study was not designed to compare intervention lengths, so the results reflect participant-determined attendance patterns rather than prescribed treatment dosage.
“The original study was not designed to compare intervention lengths, thus results reflect participant-determined attendance patterns as opposed to “prescribed” treatment dosage.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationThe Good Enough Level model proposes that optimal treatment dosage varies with individual improvement rates, so patients who improve quickly may self-modulate dosage by discontinuing early.
“The Good Enough Level (GEL) model posits that optimal treatment dosage varies as a function of individual improvement rates such that patients who improve quickly may self-modulate treatment dosage via early discontinuation (Owen et al., 2016; Reese et al., 2011).”
Quote in the paperSubstantial claim0 of 2 sources checkedClassified as probably not a substantial claim.
Study design and conductreasoningThe abstinence analysis was restricted to Completers versus Titrators because Droppers withdrew before quit week.
“Subsequent analysis of the relation between treatment attendance pattern and abstinence was restricted to the Completer versus Titrator since Droppers withdrew prior to quit week.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe present findings show that treatment attendance patterns can be empirically derived and related to efficacy, generating testable hypotheses.
“Together, the present findings show that treatment attendance patterns can be empirically-derived and related to efficacy, helping to generate testable hypotheses for follow-up studies that aim to refine interventions.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationown dataThe higher proportion of Droppers in the exercise condition may indicate that the exercise intervention was more aversive or challenging to adhere to.
“The disproportionate number of Droppers in the exercise condition may indicate that the exercise intervention was more aversive or challenging to adhere to.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductcitationIf biological verification was unavailable, abstinence was treated as missing data.
“If biological verification was not available to verify self-report, abstinence was considered missing data (Blankers et al., 2016).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Blankers et al., 2016
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Classified as probably not a substantial claim. May combine two claims.
Study design and conductcitationSelf-reported smoking status was verified by expired carbon monoxide at weekly visits and saliva cotinine at follow-up.
“Self-reported smoking status was verified by expired carbon monoxide at weekly visits, and with saliva cotinine at follow-up (SRNT Subcommittee on Biochemical Verification, 2002).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites SRNT Subcommittee on Biochemical Verification, 2002 source
The paper relies on this without support.
Knowledge about treatment attendance patterns and their relation to clinical outcomes is limited.
“While important for substance use outcomes, knowledge about treatment attendance patterns, and their relation with clinical outcomes is limited.”
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Consistentχ²(2) = 7.46reported p = .02 · recomputed p = .024
“χ2(2)=7.46, p = .02”
- Consistentt(3047) = 3.195reported p = .001 · recomputed p = .001
“t(3047)=3.195, p = .001”
- Consistentt(3047) = 1.455reported p = .146 · recomputed p = .146
“t(3047)=1.455, p = .146”
- Consistentt(3047) = 6.102reported p < .001 · recomputed p < .001
“t(3047)=6.102, p < .001”
- Consistentt(3047) = 1.054reported p = .292 · recomputed p = .292
“t(3047)=1.054, p = .292”
- Consistentt(3047) = 3.127reported p = .002 · recomputed p = .002
“t(3047)=3.127, p = .002”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Interaction confidence interval conflicts with its p-value
MajorThe reported 95% confidence interval for the attendance-by-treatment interaction includes zero, whereas the reported p=.001 indicates a statistically significant interaction. These results conflict for the same coefficient.
“95% CI [−0.293, 1.223]”
“t(3047)=3.195, p=.001”
Attendance pattern percentages do not match stated counts
MinorThe reported percentages for the three attendance classes are slightly inconsistent with the class counts out of the total sample of 136. Using the counts 63, 32, and 41 gives 46.32%, 23.53%, and 30.15%, so the last class is closer to 30.1% than 31.1%.
Reported 31.1 · recomputed 30.147059
“Three distinct attendance patterns were identified: Completers (n=63, 46.3%) had high probability of attending throughout the entire treatment duration, Titrators (n=32, 23.5%) showed a gradual decline in probability of attending throughout the 15 weeks of treatment, and Droppers (n=41, 31.1%) had a high probability of dropout within the first few weeks of treatment”
Dropper percentage does not match the class count
MinorThe reported 41 Droppers out of 136 participants represent 30.1%, not 31.1%. The abstract gives the matching percentage of 30.1%.
Reported 31.1 · recomputed 30.147059
“Droppers (n=41, 31.1%) had a high probability of dropout within the first few weeks of treatment”
Cites
Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences.
Henry, N. W., Cohen, J., & Cohen, P. R. (1977) · Contemporary Sociology A Journal of Reviews · doi:10.2307/2064799 · Cited by 7,231 · see citing works
Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences.
Tufte, E. R., Cohen, J., & Cohen, P. (1979) · Journal of the American Statistical Association · doi:10.2307/2286442 · Cited by 5,214 · cited 1× · see citing works
“To minimize Type II error, provide a more parsimonious model, and more clearly elucidate the overall relations between the predictors and abstinence, non-significant interaction terms were removed (Baldwin et al., 2009; Cohen, 1983).”
MethodTreating tobacco use and dependence-Clinical practice guideline
Mc, F. (2000) · Medical Entomology and Zoology · Cited by 3,616 · see citing works
Current Cigarette Smoking Among Adults — United States, 2016
Jamal, A., Phillips, E., Gentzke, A. S., Homa, D. M., Babb, S. D., King, B. A., & Neff, L. J. (2018) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6702a1 · Cited by 3,060 · see citing works
Current Cigarette Smoking Among Adults — United States, 2005–2014
Jamal, A., Homa, D. M., O’Connor, E., Babb, S. D., Caraballo, R. S., Singh, T., Hu, S., & King, B. A. (2015) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6444a2 · Cited by 2,544 · see citing works
Biochemical verification of tobacco use and cessation
Benowitz, N. L., III, P. J., Ahijevych, K., Jarvis, M. J., Hall, S., LeHouezec, J., Hansson, A., Lichtenstein, E., Henningfield, J., Tsoh, J., et al. (2002) · Nicotine & Tobacco Research · doi:10.1080/14622200210123581 · Cited by 1,800 · see citing works
Treating tobacco use and dependence: 2008 update: Clinical practice guideline
(2008) · PsycEXTRA Dataset · doi:10.1037/e481882008-001 · Cited by 1,219 · see citing works
Measures of abstinence in clinical trials: issues and recommendations
Hughes, J. R., Keely, J. P., NIAURA, R. S., Ossip-Klein, D. J., RICHMOND, R. L., & Swan, G. E. (2003) · Nicotine & Tobacco Research · doi:10.1093/ntr/5.1.13 · Cited by 1,058 · cited 1× · see citing works
“Failure to maintain prolonged abstinence (PA) at any assessment was defined by 7 or more consecutive days of smoking or smoking at least 1 cigarette over the 2 consecutive weeks prior to the assessment (Hughes et al., 2003; Smits et al., 2016).”
BackgroundQuitting Smoking Among Adults — United States, 2001–2010
Tanoue, L. T. (2012) · Yearbook of Medicine · doi:10.1016/s0084-3873(12)00225-8 · Cited by 737 · see citing works
Measures of abstinence in clinical trials: issues and recommendations
Hughes, J. R., Keely, J. P., NIAURA, R. S., Ossip-Klein, D. J., RICHMOND, R. L., & Swan, G. E. (2003) · Nicotine & Tobacco Research · doi:10.1080/1462220031000070552 · Cited by 712 · see citing works
Leventhal, A. M., & Zvolensky, M. J. (2015) · Psychological Bulletin · doi:10.1037/bul0000003 · Cited by 524 · cited 1× · see citing works
“Exercise may assist smoking cessation by mitigating anxiety during acute withdrawal symptoms (Leventhal and Zvolensky, 2015), which may be most pronounced after the initial quit attempt.”
BackgroundSelf-citationQuitting smoking among adults--United States, 2001-2010.
(2011) · PubMed · Cited by 495 · see citing works
The Efficacy of Exercise as an Aid for Smoking Cessation in Women: A Randomized Controlled Trial
Marcus, B. H., Albrecht, A. E., King, T. K., Parisi, A. F., Pinto, B. M., Roberts, M., Niaura, R. S., & Abrams, D. B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.11.1229 · Cited by 384 · cited 1× · see citing works
“Although effective treatments exist, completion rates reported in smoking cessation trials range from 50%–70% (Baker et al., 2006; Borrelli et al., 2002; Curtin et al., 2000; Evins et al., 2008; Marcus et al., 1999).”
BackgroundSelf-citationUs Public Health Service Clinical Practice Guideline: Treating Tobacco Use and Dependence
Fiore, M. C., & Staff, G. P. A. (2000) · Respiratory Care · doi:10.1177/002013240004501007 · Cited by 346 · cited 1× · see citing works
“2.2 Interventions All participants received a standard treatment (Fiore, 2000; Zvolensky et al., 2008) of seven weekly 60-minute sessions of cognitive behavioral therapy for smoking cessation and optional nicotine replacement therapy (NRT).”
BackgroundInfluentialReducing anxiety sensitivity with exercise
Smits, J. A. J., Berry, A. C., Rosenfield, D., Powers, M. B., Behar, E., & Otto, M. W. (2008) · Depression and Anxiety · doi:10.1002/da.20411 · Cited by 298 · cited 1× · see citing works
“Given evidence of rapid benefits from exercise on anxiety, mood, and anxiety sensitivity in other studies (Medina et al., 2014; Smits et al., 2008), exercise may exert its influence on risk factors for smoking relapse in only a few sessions early on in treatment.”
BackgroundSelf-citationDose-effect relations and responsive regulation of treatment duration: The good enough level.
Barkham, M., Connell, J., Stiles, W. B., Miles, J. N. V., Margison, F., Evans, C., & Mellor-Clark, J. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.1.160 · Cited by 293 · cited 2× · see citing works
“…have shown positive associations with outcomes (Baker et al., 2006; Fiore, 2008; Smits et al., 2016; Whiteley et al., 2012), but this is not ubiquitous, suggesting individual differences in dose-response exist (Baldwin et al., 2009; Barkham et al., 2006; Owen et al., 2016; Reese et al., 2011).”
BackgroundBaldwin, S. A., Berkeljon, A., Atkins, D. C., Olsen, J. A., & Nielsen, S. L. (2009) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0015235 · Cited by 274 · cited 3× · see citing works
“…have shown positive associations with outcomes (Baker et al., 2006; Fiore, 2008; Smits et al., 2016; Whiteley et al., 2012), but this is not ubiquitous, suggesting individual differences in dose-response exist (Baldwin et al., 2009; Barkham et al., 2006; Owen et al., 2016; Reese et al., 2011).”
BackgroundMethodBaker, A., Richmond, R., Haile, M., Lewin, T. J., Carr, V. J., Taylor, R. L., Jansons, S., & Wilhelm, K. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1934 · Cited by 255 · cited 3× · see citing works
“In some cases, a greater number of sessions attended or treatment completion have shown positive associations with outcomes (Baker et al., 2006; Fiore, 2008; Smits et al., 2016; Whiteley et al., 2012), but this is not ubiquitous, suggesting individual differences in dose-response exist (Baldwin et…”
BackgroundHall, S. M., Delucchi, K. L., Velicer, W. F., Kahler, C. W., Ranger-Moore, J., Hedeker, D., Tsoh, J. Y., & Niaura, R. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200110050411 · Cited by 188 · cited 2× · see citing works
“, pre-quit, post-quit, post-treatment) generalized linear mixed model (GLMM) following the intent-to-treat approach recommended for smoking cessation trials (Hall et al., 2001).”
MethodSmits, J. A. J., Zvolensky, M. J., Davis, M. L., Rosenfield, D., Marcus, B. H., Church, T. S., Powers, M. B., Frierson, G. M., Otto, M. W., Hopkins, L. B., et al. (2016) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000264 · Cited by 103 · cited 6× · see citing works
“…a greater number of sessions attended or treatment completion have shown positive associations with outcomes (Baker et al., 2006; Fiore, 2008; Smits et al., 2016; Whiteley et al., 2012), but this is not ubiquitous, suggesting individual differences in dose-response exist (Baldwin et al.,…”
BackgroundResultInfluentialSelf-citationZvolensky, M. J., Yartz, A. R., Gregor, K., Gonzalez, A., & Bernstein, A. (2008) · Journal of Cognitive Psychotherapy · doi:10.1891/0889-8391.22.4.346 · Cited by 89 · cited 2× · see citing works
“2.2 Interventions All participants received a standard treatment (Fiore, 2000; Zvolensky et al., 2008) of seven weekly 60-minute sessions of cognitive behavioral therapy for smoking cessation and optional nicotine replacement therapy (NRT).”
BackgroundInfluentialSelf-citationPredictors of quitting and dropout among women in a clinic-based smoking cessation program.
Borrelli, B., Hogan, J. W., Bock, B. C., Pinto, B. M., Roberts, M., & Marcus, B. H. (2002) · Psychology of Addictive Behaviors · doi:10.1037/0893-164x.16.1.22 · Cited by 69 · cited 1× · see citing works
“Although effective treatments exist, completion rates reported in smoking cessation trials range from 50%–70% (Baker et al., 2006; Borrelli et al., 2002; Curtin et al., 2000; Evins et al., 2008; Marcus et al., 1999).”
BackgroundSelf-citationEvins, A. E., Maravić, M. C., Alpert, J. E., Pava, J. A., Liese, B. S., Farabaugh, A. H., & D, M. F. M. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31818ad7d6 · Cited by 67 · cited 1× · see citing works
“Although effective treatments exist, completion rates reported in smoking cessation trials range from 50%–70% (Baker et al., 2006; Borrelli et al., 2002; Curtin et al., 2000; Evins et al., 2008; Marcus et al., 1999).”
BackgroundThe Missing=Smoking Assumption: A Fallacy in Internet-Based Smoking Cessation Trials?
Blankers, M., Smit, E. S., van der Pol, P., de Vries, H., Hoving, C., & van Laar, M. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntv055 · Cited by 61 · cited 2× · see citing works
“If biological verification was not available to verify self-report, abstinence was considered missing data (Blankers et al., 2016).”
MethodGood-enough level and dose-effect models: variation among outcomes and therapists
Owen, J. J., Adelson, J., Budge, S., Kopta, S. M., & Reese, R. J. (2016) · Psychotherapy Research · doi:10.1080/10503307.2014.966346 · Cited by 58 · cited 3× · see citing works
“…have shown positive associations with outcomes (Baker et al., 2006; Fiore, 2008; Smits et al., 2016; Whiteley et al., 2012), but this is not ubiquitous, suggesting individual differences in dose-response exist (Baldwin et al., 2009; Barkham et al., 2006; Owen et al., 2016; Reese et al., 2011).”
BackgroundReplicating and extending the good-enough level model of change: considering session frequency
Reese, R. J., Toland, M. D., & Hopkins, N. B. (2011) · Psychotherapy Research · doi:10.1080/10503307.2011.598580 · Cited by 58 · cited 4× · see citing works
“…have shown positive associations with outcomes (Baker et al., 2006; Fiore, 2008; Smits et al., 2016; Whiteley et al., 2012), but this is not ubiquitous, suggesting individual differences in dose-response exist (Baldwin et al., 2009; Barkham et al., 2006; Owen et al., 2016; Reese et al., 2011).”
BackgroundResultInfluentialCurtin, L., Brown, R. A., & Sales, S. D. (2000) · Psychology of Addictive Behaviors · doi:10.1037//0893-164x.14.2.134 · Cited by 58 · cited 1× · see citing works
“Although effective treatments exist, completion rates reported in smoking cessation trials range from 50%–70% (Baker et al., 2006; Borrelli et al., 2002; Curtin et al., 2000; Evins et al., 2008; Marcus et al., 1999).”
BackgroundCurtin, L., Brown, R. A., & Sales, S. D. (2000) · Psychology of Addictive Behaviors · doi:10.1037/0893-164x.14.2.134 · Cited by 54 · see citing works
Attendance and substance use outcomes for the Seeking Safety program: sometimes less is more
Hien, D. A., Morgan-Lopez, A. A., Campbell, A. N. C., Saavedra, L. M., Wu, E., Cohen, L., Ruglass, L., & Nunes, E. V. (2012) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0026361 · Cited by 50 · cited 2× · see citing works
“Another treatment trial for comorbid PTSD and SUD used a person-centered approach to empirically derive distinct attendance patterns of early dropout, titration, and completion—importantly; treatment titration was not associated with poorer outcomes relative to completion (Hien et al., 2012).”
BackgroundResultZandberg, L. J., Rosenfield, D., Alpert, E., McLean, C. P., & Foa, E. B. (2016) · Behaviour Research and Therapy · doi:10.1016/j.brat.2016.02.005 · Cited by 45 · cited 2× · see citing works
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript each associated with early dropout (Zandberg et al., 2016).”
BackgroundSelf-citationSmits, J. A. J., Zvolensky, M. J., Rosenfield, D., Marcus, B. H., Church, T. S., Frierson, G. M., Powers, M. B., Otto, M. W., Davis, M. L., Hopkins, L. B., et al. (2012) · Trials · doi:10.1186/1745-6215-13-207 · Cited by 37 · cited 2× · see citing works
“For a detailed description of the procedures see (Smits et al., 2012).”
BackgroundSelf-citationWhiteley, J. A., Williams, D. M., DUNSIGER, S. I., Jennings, E., Ciccolo, J. T., Bock, B. C., Albrecht, A. E., Parisi, A. F., Linke, S., & Marcus, B. H. (2012) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.05.025 · Cited by 30 · cited 2× · see citing works
“In some cases, a greater number of sessions attended or treatment completion have shown positive associations with outcomes (Baker et al., 2006; Fiore, 2008; Smits et al., 2016; Whiteley et al., 2012), but this is not ubiquitous, suggesting individual differences in dose-response exist (Baldwin et al.”
BackgroundSelf-citationGender moderates the effect of exercise on anxiety sensitivity
Medina, J. L., DeBoer, L. B., Davis, M. L., Rosenfield, D., Powers, M. B., Otto, M. W., & Smits, J. A. J. (2014) · Mental Health and Physical Activity · doi:10.1016/j.mhpa.2014.08.002 · Cited by 21 · cited 1× · see citing works
“Given evidence of rapid benefits from exercise on anxiety, mood, and anxiety sensitivity in other studies (Medina et al., 2014; Smits et al., 2008), exercise may exert its influence on risk factors for smoking relapse in only a few sessions early on in treatment.”
BackgroundSelf-citationImproving efficiency of initial tests for efficacy in smoking cessation drug discovery
Perkins, K. A. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.951632 · Cited by 11 · cited 1× · see citing works
“Since success with abstinence within the first 24 hours after quit is predictive of continued abstinence (Perkins, 2014), Titrators who were likely to remain engaged in the exercise intervention through quit week may have benefited comparably to Completers despite lower overall attendance.”
Background
Flagged first, then by citations
3 of the 37 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Rose, E. J., Picci, G., & Fishbein, D. H. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00399 · Cited by 30 · see citing works
Predictors of client retention in a state-based tobacco quitline
Nair, U. S., Rabe, B. A., Brady, B. R., & Bell, M. L. (2020) · The Journal of Smoking Cessation · doi:10.1017/jsc.2020.10 · Cited by 10 · see citing works
Straus, E., Worley, M. J., Lyons, R. C., Kline, A. C., Tripp, J. C., Davis, B. C., Haller, M. M., Angkaw, A. C., Trim, R. S., & Norman, S. B. (2021) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2021.102498 · Cited by 9 · see citing works
Garey, L., Rogers, A. H., Manning, K. F., Smit, T., Derrick, J. L., Viana, A. G., Schmidt, N. B., & Zvolensky, M. J. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.10.006 · Cited by 8 · see citing works
“Emerging work, however, suggests that there may be a more nuanced patterning to smoking cessation treatment attendance that is not captured by these traditional modeling efforts (Jacquart et al., 2017).”
BackgroundMethodSelf-citationWillingness-to-try various tobacco cessation methods among US adult cigarette smokers
Enyioha, C., Meernik, C., Ranney, L. M., Goldstein, A. O., Sellman, K., & Kistler, C. E. (2019) · Tobacco Prevention & Cessation · doi:10.18332/tpc/108555 · Cited by 7 · see citing works
Treatment completion and anxiety sensitivity effects on smoking cessation outcomes
Martínez-Vispo, C., López‐Durán, A., Rodríguez‐Cano, R., Senra, C., & Becoña, E. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.106856 · Cited by 6 · see citing works
Age and pre quit-day attrition during smoking cessation treatment
Conroy, H. E., Jacquart, J., Baird, S. O., Rosenfield, D., Davis, M. L., Powers, M. B., Frierson, G. M., Marcus, B. H., Otto, M. W., Zvolensky, M. J., et al. (2020) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2020.1751262 · Cited by 4 · see citing works
Self-citationSancho-Domingo, C., Carballo, J. L., Coloma‐Carmona, A., Román, C. J. V.-D. H., del Castillo‐López, Á. G., & Sánchez, S. A. (2023) · Substance Use & Misuse · doi:10.1080/10826084.2023.2262021
“In addition, and consistent with previous studies (Jacquart et al., 2017; Raupach et al., 2014), a longer use of varenicline and attending to more GSC therapy sessions doubled the chance for abstinence (RR = 1.94; 95%CI = 1.34, 2.81).”
Influential
- Authors
- Jacquart, J., Papini, S., Davis, M. L., Rosenfield, D., Powers, M. B., Frierson, G. M., Hopkins, L. B., Baird, S. O., Marcus, B. H., Church, T. S., Otto, M. W., Zvolensky, M. J., & Smits, J. A. J.
- Affiliations
- The University of Texas at Austin (US)
- Southern Methodist University (US)
- Baylor University Medical Center (US)
- Rowan University (US)
- VA Palo Alto Health Care System (US)
- University of California San Diego (US)
- Pennington Biomedical Research Center (US)
- Boston University (US)
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Jacquart, Jolene
- ORCID
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 174
- Pages
- 65-69
- ISSN
- 0376-8716 (ISSN-L)
- PMC
- PMC5423398
- OpenAlex
- W2593105591
- Cited by
- 8
- References
- 37
- Citations by year
- 2023: 1 · 2021: 2 · 2020: 2 · 2019: 3
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Drug and Alcohol Dependence (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institutes of Health (5r01da027533-04)
- National Institute on Drug Abuse (R01-DA027533)
- Topics
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Psychology › Applied Psychology › Behavioral Health and Interventions
- Keywords
- smoking cessation, treatment discontinuation, abstinence, exercise intervention, treatment completion, latent class growth analysis
- MeSH terms
- Adult, Exercise Therapy, Female, Humans, Male, Middle Aged, Patient Acceptance of Health Care, Patient Dropouts, Smoking, Smoking Cessation, Treatment Outcome, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read under definition version 3 (extract-v3) on 2026-09-28.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-28.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review